Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05325853 · ClinicalTrials.gov registry record · Phase 3
A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population
A Phase 3 study of Anesthesia, Local, sponsored by American Genomics.
- Completed
- Registry status
- Phase 3
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT05325853: Completed Phase 3 study of Anesthesia, Local, sponsored by American Genomics.
NCT05325853 is a Phase 3 study of Anesthesia, Local that has completed, run by American Genomics. The registered enrollment target is 61 participants, below the 80-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05325853, a Phase 3 study of Anesthesia, Local, has completed, sponsored by American Genomics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
A Phase 3, randomized, active-controlled, study in pediatric subjects. It is designed to evaluate the safety and anesthetic efficacy of one dose of AG-920 ophthalmic solution compared to Proparacaine Hydrochloride Ophthalmic Solution.
Primary Outcome
Was the investigator was able to perform the eye examination without additional anesthesia
Conditions Studied
Interventions
- DRUG Proparacaine Ophthalmic
- DRUG AG-920
Study Locations (1)
Texas
- American Genomics Site 2 - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2022-05-27 |
| Phase | Phase 3 |
What the finished NCT05325853 record still lists
NCT05325853 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 80-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Anesthesia, Local appearing as the primary indexed condition, and to 2 interventions - of which Proparacaine Ophthalmic is the first listed.
NCT05325853 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05325853 about?
NCT05325853 is a clinical study titled "A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population". A Phase 3, randomized, active-controlled, study in pediatric subjects. It is designed to evaluate the safety and anesthetic efficacy of one dose of AG-920 ophthalmic solution compared to Proparacaine Hydrochloride Ophthalmic Solution.
What is the current status of trial NCT05325853?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 61 participants. The study started on 2022-04-06. Estimated completion is 2022-05-27.
What conditions does trial NCT05325853 study?
This clinical trial studies the following conditions: Anesthesia, Local.
What interventions are being tested in trial NCT05325853?
The interventions under investigation include: Proparacaine Ophthalmic (DRUG), AG-920 (DRUG).
Who is sponsoring clinical trial NCT05325853?
This trial is sponsored by American Genomics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05325853 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia, Local
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05325853's enrollment target sits among peer trials
61 10th of 18 higher than 9 of 18 other Anesthesia, Local trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia, Local trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution
COMPLETED · Phase 3
-
A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults
RECRUITING · NA
-
Effect of Silver Diamine Fluoride on Local Anesthesia in Hypomineralized Molars
RECRUITING · NA
-
Obstetric Placement Study Using EST
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Split Face Study of the Duration of Local Anesthetics - Fourth Arm
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI